SCHEMBL29133735

SCHEMBL29133735

CCC1(Nc2ncnc3ccc(I)cc23)C=CC=CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.36
▸ CCNC P24863 1/20 0.36
▸ CDK8 P49336 1/20 0.36
▸ FBP1 P09467 1/20 0.35
▸ EGFR P00533 7/20 0.34
▸ ERBB2 P04626 1/20 0.34
▸ ERBB4 Q15303 1/20 0.34
▸ CD38 P28907 1/20 0.34
▸ FLT1 P17948 1/20 0.33
▸ IRAK4 Q9NWZ3 4/20 0.32
▸ CLK1 P49759 2/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CLK2 P49760 1/20 0.32
▸ CLK3 P49761 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32
▸ CLK4 Q9HAZ1 1/20 0.32
▸ DYRK1B Q9Y463 1/20 0.32
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133752 1.00 HTT (0.36) HTTCCNCCDK8FBP1EGFR
SCHEMBL29133739 0.87 HTT (0.50) HTTCCNCCDK8IRAK4LMNA
SCHEMBL29133745 0.87 HTT (0.50) HTTCCNCCDK8IRAK4LMNA
SCHEMBL29133728 0.81 IRAK4 (0.48) EGFRCD38IRAK4CLK1MAP4K4
SCHEMBL29133774 0.79 IRAK4 (0.47) EGFRCD38IRAK4MAP4K4LMNA
SCHEMBL29133716 0.78 IRAK4 (0.39) EGFRIRAK4CLK1MAP4K4CLK4
SCHEMBL27736388 0.77 KDM4E (0.35) HTTEGFRFLT1IRAK4LMNA
SCHEMBL29133742 0.77 IRAK4 (0.35) CD38IRAK4CLK1MAP4K4CLK2
SCHEMBL29133743 0.77 PIK3CA (0.53) CLK1MAP4K4CLK2CLK3DYRK1A
SCHEMBL29133732 0.77 PIK3CA (0.52) EGFRIRAK4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback